JBT Marel Corporation

JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) supplies equipment, processing systems, software and services to food and beverage producers. Its Protein Solutions segment serves businesses including poultry processors. Prepared Food and Beverage Solutions covers further processing, packaging and other food, beverage and health-related applications.

The former John Bean Technologies acquired control of Marel on January 2, 2025, and bought the remaining minority interest on February 4. Both comparative third quarters include Marel throughout. The current Protein and Prepared Food segments replaced the former reporting structure, with comparative figures recast to match.

Quarterly performance

Net income margin reached a record 7%, while adjusted EBITDA margin reached a record 18%. Lower interest expense helped net income even as operating income edged down. Adjusted EBITDA removes interest, taxes, depreciation, amortization and selected acquisition, integration, restructuring, impairment and other items. Adjusted EPS uses separately reconciled exclusions and tax effects.

Protein revenue rose 6% to $469 million, while Prepared Food and Beverage revenue fell 6% to $525 million. Both segments improved adjusted EBITDA margins. Management cited synergies, pricing and mix, with softer quick-turn business weighing on Prepared Food.

The revised outlook

November's 2026 revenue range is $3.950 billion–$4.000 billion, versus August's $3.990 billion–$4.065 billion. The adjusted EBITDA range moved to $681 million–$700 million from $675 million–$710 million. Its midpoint is nearly unchanged.

Adjusted diluted EPS moved to $8.10–$8.40 from $7.85–$8.35. Management credits lower interest, taxes and share count. The GAAP EPS midpoint stayed at $4.45. The adjusted forecast also excludes accelerated noncash debt-cost amortization.

Orders of $976 million exceeded the year-earlier $946 million. September backlog was $1.516 billion, above $1.339 billion a year earlier but below June's $1.536 billion.

Buyback capacity and cash funding

The board added $500 million to the repurchase program on October 30, bringing lifetime authority to $700 million. The program had already used approximately $120 million through September, including $94 million in the third quarter. September unused capacity was about $80 million before the increase.

Nine-month operating cash flow was $320 million, versus $224 million. The company's free cash flow measure was $252 million versus $163 million. It deducts capital spending from operating cash and adds asset-disposal proceeds and pension contributions.

Comparing the nine-month and original first-half statements gives $73 million of third-quarter free cash flow. Quarterly repurchases exceeded that amount by $21 million. The cash statement also includes proceeds from settling investment hedges.

Debt and the capital-allocation test

At September 30, unrestricted cash was $98 million and reported debt was $1.694 billion. Net debt, which subtracts that cash from the debt carrying amount, was $1.596 billion. It rose from June's $1.586 billion but remained below $1.714 billion at year-end.

Net debt was 2.45 times adjusted EBITDA for the past 12 months, compared with 2.47 times in June. Management's long-term expectation is 2.0–2.5 times. Further purchases will show how it balances returns to shareholders with borrowing, investment and the conversion of orders into cash.